Lannett Co Company Profile (NYSE:LCI)

About Lannett Co (NYSE:LCI)

Lannett Co logoLannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc. As of June 30, 2016, the Company's products included Acetazolamide Tablets; Butalbital, Acetaminophen and Caffeine Tablets; Butalbital, Aspirin and Caffeine Capsules; C-Topical Solution; Digoxin Tablets; Glycolax Rx; Isosorbide Mononitrate CR; Levothyroxine Sodium Tablets; Methylphenidate HCL CD; Methylphenidate ER; Nifedipine CR; Omeprazole DR; Oxbutynin ER; Pantoprazole DR; Pilocarpine HCl Tablets; Triamterene w/Hydrochlorothiazide Capsules, and Ursodiol Capsules. The Company has additional products under development, which are orally administered solid oral-dosage products (tablet/capsule) or oral solutions, nasal, topicals or parentarels, as well as other dosage forms.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Pharmaceuticals - NEC
  • Sub-Industry: Pharmaceuticals
  • Symbol: NYSE:LCI
  • CUSIP: 51601210
  • Web: www.lannett.com
Capitalization:
  • Market Cap: $742.75 million
  • Outstanding Shares: 37,230,000
Average Prices:
  • 50 Day Moving Avg: $20.48
  • 200 Day Moving Avg: $21.95
  • 52 Week Range: $16.75 - $39.99
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 7.14
  • P/E Growth: -0.84
Sales & Book Value:
  • Annual Revenue: $667.11 million
  • Price / Sales: 1.16
  • Book Value: $15.02 per share
  • Price / Book: 1.38
Profitability:
  • EBIDTA: $261.24 million
  • Net Margins: -0.41%
  • Return on Equity: 22.13%
  • Return on Assets: 6.99%
Debt:
  • Debt-to-Equity Ratio: 1.54%
  • Current Ratio: 2.63%
  • Quick Ratio: 2.04%
Misc:
  • Average Volume: 740,791 shs.
  • Beta: 2.66
  • Short Ratio: 16.76
 

Frequently Asked Questions for Lannett Co (NYSE:LCI)

What is Lannett Co's stock symbol?

Lannett Co trades on the New York Stock Exchange (NYSE) under the ticker symbol "LCI."

How were Lannett Co's earnings last quarter?

Lannett Co Inc (NYSE:LCI) announced its earnings results on Tuesday, May, 2nd. The company reported $0.77 earnings per share for the quarter, missing the consensus estimate of $0.87 by $0.10. The company earned $165.72 million during the quarter, compared to analysts' expectations of $170.28 million. Lannett Co had a negative net margin of 0.41% and a positive return on equity of 22.13%. View Lannett Co's Earnings History.

When will Lannett Co make its next earnings announcement?

Lannett Co is scheduled to release their next quarterly earnings announcement on Monday, August, 21st 2017. View Earnings Estimates for Lannett Co.

Where is Lannett Co's stock going? Where will Lannett Co's stock price be in 2017?

6 brokerages have issued 1 year target prices for Lannett Co's stock. Their forecasts range from $18.00 to $43.00. On average, they expect Lannett Co's share price to reach $28.60 in the next year. View Analyst Ratings for Lannett Co.

Who are some of Lannett Co's key competitors?

Who are Lannett Co's key executives?

Lannett Co's management team includes the folowing people:

  • Jeffrey Farber, Chairman of the Board
  • Arthur P. Bedrosian J.D., Chief Executive Officer, Director
  • Martin P. Galvan CPA, Chief Financial Officer, Vice President - Finance, Treasurer
  • Robert Ehlinger, Vice President - Logistics, Chief Information Officer
  • Kevin R. Smith, Vice President - Sales and Marketing
  • John M. Abt, Vice President of Quality
  • Kristin A. Arnold, Vice President - Research and Development
  • David Drabik, Lead Independent Director
  • James M. Maher, Independent Director
  • Albert Paonessa III, Independent Director

Who owns Lannett Co stock?

Lannett Co's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Telemus Capital LLC (16.43%), BlackRock Inc. (10.50%), Snow Capital Management LP (8.32%), Vanguard Group Inc. (7.35%), LSV Asset Management (4.55%) and Morgan Stanley (3.60%). Company insiders that own Lannett Co stock include Arthur P Bedrosian, David A Drabik, David Farber, G Michael Landis, James M Maher, John Abt, Kevin Smith, Martin P Galvan and Robert Ehlinger. View Institutional Ownership Trends for Lannett Co.

Who sold Lannett Co stock? Who is selling Lannett Co stock?

Lannett Co's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Telemus Capital LLC, Wells Fargo & Company MN, DUPONT CAPITAL MANAGEMENT Corp, First Trust Advisors LP, Muhlenkamp & Co. Inc., Pinnacle Associates Ltd. and Dimensional Fund Advisors LP. Company insiders that have sold Lannett Co stock in the last year include David Farber, G Michael Landis and James M Maher. View Insider Buying and Selling for Lannett Co.

Who bought Lannett Co stock? Who is buying Lannett Co stock?

Lannett Co's stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, Snow Capital Management LP, Heartland Advisors Inc., LSV Asset Management, Rafferty Asset Management LLC, Vanguard Group Inc. and Prudential Financial Inc.. Company insiders that have bought Lannett Co stock in the last two years include Arthur P Bedrosian, David A Drabik, John Abt, Kevin Smith and Martin P Galvan. View Insider Buying and Selling for Lannett Co.

How do I buy Lannett Co stock?

Shares of Lannett Co can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Lannett Co's stock price today?

One share of Lannett Co stock can currently be purchased for approximately $20.70.


MarketBeat Community Rating for Lannett Co (NYSE LCI)
Community Ranking:  2.9 out of 5 ( )
Outperform Votes:  221 (Vote Outperform)
Underperform Votes:  158 (Vote Underperform)
Total Votes:  379
MarketBeat's community ratings are surveys of what our community members think about Lannett Co and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Lannett Co (NYSE:LCI) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Hold Ratings, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $28.60 (38.16% upside)

Analysts' Ratings History for Lannett Co (NYSE:LCI)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
6/8/2017Oppenheimer Holdings, Inc.Reiterated RatingHoldHighView Rating Details
5/2/2017Roth CapitalSet Price TargetBuy$27.00MediumView Rating Details
5/3/2017Robert W. BairdReiterated RatingOutperform$18.00MediumView Rating Details
5/1/2017BMO Capital MarketsInitiated CoverageMarket Perform$29.00MediumView Rating Details
10/18/2016Deutsche Bank AGReiterated RatingHold$32.00 -> $26.00N/AView Rating Details
8/24/2016Raymond James Financial, Inc.Boost Price TargetOutperform$31.00 -> $43.00N/AView Rating Details
3/25/2016Susquehanna Bancshares IncLower Price Target$37.00 -> $30.00N/AView Rating Details
3/25/2016Craig HallumLower Price TargetBuy$35.00N/AView Rating Details
3/24/2016Canaccord GenuityDowngradeBuy -> Sell$28.00 -> $18.00N/AView Rating Details
(Data available from 6/27/2015 forward)

Earnings

Earnings History for Lannett Co (NYSE:LCI)
Earnings by Quarter for Lannett Co (NYSE:LCI)
Earnings History by Quarter for Lannett Co (NYSE LCI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/21/2017        
5/2/2017Q3 2017$0.87$0.77$170.28 million$165.72 millionViewListenView Earnings Details
2/1/2017Q217$0.84$0.92$169.04 million$171.00 millionViewListenView Earnings Details
11/3/2016Q117$0.71$0.77$166.72 million$161.60 millionViewN/AView Earnings Details
8/23/2016Q416$0.59$0.73$161.55 million$168.90 millionViewListenView Earnings Details
5/3/2016Q316$0.63$0.75$160.49 million$163.70 millionViewN/AView Earnings Details
2/3/2016Q216$0.94$0.95$141.62 million$127.06 millionViewN/AView Earnings Details
11/4/2015Q116$0.89$0.99$103.90 million$106.40 millionViewN/AView Earnings Details
8/25/2015Q415$0.86$0.91$97.21 million$99.28 millionViewListenView Earnings Details
5/6/2015Q315$0.94$0.97$101.10 million$99.40 millionViewN/AView Earnings Details
2/4/2015Q215$1.06$1.21$102.95 million$114.80 millionViewN/AView Earnings Details
11/3/2014Q115$0.79$0.94$91.40 million$93.40 millionViewN/AView Earnings Details
8/27/2014Q414$0.63$0.64$79.50 million$80.60 millionViewN/AView Earnings Details
5/7/2014Q314$0.60$0.63$84.50 million$80.00 millionViewN/AView Earnings Details
2/6/2014Q214$0.39$0.46$62.21 million$67.30 millionViewN/AView Earnings Details
11/7/2013Q114$0.13$0.22$41.14 million$45.82 millionViewN/AView Earnings Details
9/10/2013Q4 2013$0.07$0.12$37.89 million$40.20 millionViewN/AView Earnings Details
5/8/2013Q3 2013$0.13$0.14$35.14 million$39.00 millionViewN/AView Earnings Details
2/7/2013Q2 2013$0.05$0.10$33.53 million$36.60 millionViewN/AView Earnings Details
11/8/2012Q113$0.05$0.07$33.76 million$35.30 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Lannett Co (NYSE:LCI)
2017 EPS Consensus Estimate: $3.28
2018 EPS Consensus Estimate: $2.89
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.65$0.73$0.69
Q2 20173$0.80$0.91$0.86
Q3 20173$0.82$0.93$0.89
Q4 20173$0.74$0.93$0.84
Q1 20181$0.68$0.68$0.68
Q2 20181$0.76$0.76$0.76
Q3 20181$0.72$0.72$0.72
Q4 20181$0.73$0.73$0.73
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Lannett Co (NYSE:LCI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Lannett Co (NYSE:LCI)
Insider Ownership Percentage: 15.04%
Institutional Ownership Percentage: 98.69%
Insider Trades by Quarter for Lannett Co (NYSE:LCI)
Institutional Ownership by Quarter for Lannett Co (NYSE:LCI)
Insider Trades by Quarter for Lannett Co (NYSE:LCI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/6/2017Arthur P BedrosianCEOBuy10,000$20.00$200,000.00View SEC Filing  
12/2/2016David FarberMajor ShareholderSell3,800$25.00$95,000.00View SEC Filing  
9/15/2016G. Michael LandisInsiderSell4,334$32.30$139,988.20View SEC Filing  
9/1/2016James M MaherDirectorSell1,478$33.91$50,118.98View SEC Filing  
8/31/2016G. Michael LandisInsiderSell6,786$33.41$226,720.26View SEC Filing  
6/23/2016Robert EhlingerVPSell37,141$25.06$930,753.46View SEC Filing  
6/20/2016Robert EhlingerVPSell62,859$25.40$1,596,618.60View SEC Filing  
3/1/2016Robert EhlingerVPSell69,247$25.41$1,759,566.27View SEC Filing  
2/5/2016Arthur P BedrosianCEOBuy4,500$24.91$112,095.00View SEC Filing  
2/5/2016David A DrabikDirectorBuy1,277$24.74$31,592.98View SEC Filing  
2/5/2016Kevin SmithVPBuy1,500$24.75$37,125.00View SEC Filing  
2/5/2016Martin P GalvanCFOBuy3,000$24.65$73,950.00View SEC Filing  
9/15/2015Arthur P BedrosianCEOSell5,000$55.64$278,200.00View SEC Filing  
9/8/2015John AbtVPBuy1,000$54.77$54,770.00View SEC Filing  
8/17/2015Arthur P BedrosianCEOSell5,000$52.81$264,050.00View SEC Filing  
7/15/2015Arthur P BedrosianCEOSell5,000$61.92$309,600.00View SEC Filing  
6/15/2015Arthur P BedrosianCEOSell5,000$56.31$281,550.00View SEC Filing  
5/15/2015Arthur P BedrosianCEOSell5,000$53.27$266,350.00View SEC Filing  
4/15/2015Arthur P BedrosianCEOSell5,000$69.43$347,150.00View SEC Filing  
3/16/2015Arthur P BedrosianCEOSell5,000$65.23$326,150.00View SEC Filing  
3/16/2015William SchreckCOOSell134,635$64.99$8,749,928.65View SEC Filing  
3/6/2015William SchreckCOOSell50,000$63.35$3,167,500.00View SEC Filing  
2/18/2015David A DrabikDirectorSell12,500$61.55$769,375.00View SEC Filing  
2/17/2015Arthur P BedrosianCEOSell5,000$59.89$299,450.00View SEC Filing  
2/17/2015G. Michael LandisInsiderSell11,500$58.60$673,900.00View SEC Filing  
2/13/2015Jeffrey FarberDirectorSell35,000$58.18$2,036,300.00View SEC Filing  
2/11/2015Kevin SmithVPSell109,436$56.51$6,184,228.36View SEC Filing  
2/9/2015David FarberMajor ShareholderSell2,500$55.00$137,500.00View SEC Filing  
2/9/2015Kevin SmithVPSell53,534$55.36$2,963,642.24View SEC Filing  
2/6/2015G. Michael LandisInsiderSell12,049$52.93$637,753.57View SEC Filing  
1/26/2015David FarberMajor ShareholderSell7,500$50.00$375,000.00View SEC Filing  
1/15/2015Arthur P BedrosianCEOSell5,000$43.50$217,500.00View SEC Filing  
12/15/2014Arthur P BedrosianCEOSell5,000$43.81$219,050.00View SEC Filing  
12/10/2014Martin P GalvanCFOBuy1,000$42.40$42,400.00View SEC Filing  
12/8/2014Ernest SaboVPSell6,000$48.03$288,180.00View SEC Filing  
10/27/2014David FarberMajor ShareholderSell7,500$50.00$375,000.00View SEC Filing  
9/16/2014Arthur P BedrosianCEOSell5,000$40.05$200,250.00View SEC Filing  
8/18/2014David FarberMajor ShareholderSell5,000$41.30$206,500.00View SEC Filing  
7/15/2014Arthur P BedrosianCEOSell5,000$47.19$235,950.00View SEC Filing  
6/23/2014David FarberMajor ShareholderSell7,500$50.00$375,000.00View SEC Filing  
6/16/2014Arthur P BedrosianCEOSell5,000$46.96$234,800.00View SEC Filing  
6/16/2014David FarberMajor ShareholderSell10,000$43.53$435,300.00View SEC Filing  
6/16/2014Paul TaveiraDirectorSell1,000$46.94$46,940.00View SEC Filing  
3/17/2014William SchreckCOOSell16,600$43.85$727,910.00View SEC Filing  
3/12/2014William SchreckCOOSell55,563$43.31$2,406,433.53View SEC Filing  
2/20/2014Kevin SmithVPSell64,665$45.11$2,917,038.15View SEC Filing  
2/13/2014Kevin SmithVPSell20,000$40.48$809,600.00View SEC Filing  
12/13/2013Arthur BedrosianCEOBuy5,000$27.85$139,250.00View SEC Filing  
12/13/2013Martin GalvanCFOBuy3,000$26.90$80,700.00View SEC Filing  
5/14/2013Kevin SmithVPSell24,984$11.86$296,310.24View SEC Filing  
5/13/2013Kevin SmithVPSell41,929$11.80$494,762.20View SEC Filing  
5/10/2013Ernest SaboVPSell15,000$11.29$169,350.00View SEC Filing  
3/14/2013Paul TaveiraDirectorBuy1,000$9.73$9,730.00View SEC Filing  
2/13/2013Martin P GalvanCFOBuy4,000$6.88$27,520.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Lannett Co (NYSE:LCI)
Latest Headlines for Lannett Co (NYSE:LCI)
Source:
DateHeadline
prnewswire.com logoLannett Receives Approval For Additional Dosage Strengths Of Hydrocodone ...
www.prnewswire.com - June 26 at 8:10 PM
finance.yahoo.com logoLannett Receives Approval For Additional Dosage Strengths Of Hydrocodone Bitartrate And Acetaminophen Tablets USP
finance.yahoo.com - June 26 at 8:10 PM
finance.yahoo.com logoLannett Receives Approval For Hydrocodone Bitartrate and Acetaminophen Tablets USP, 5 mg/300 mg, 7.5 mg/300 mg And 10 mg/300 mg
finance.yahoo.com - June 22 at 12:35 PM
finance.yahoo.com logoLannett Names Patrick G. LePore To Board of Directors
finance.yahoo.com - June 20 at 7:13 PM
finance.yahoo.com logoETFs with exposure to Lannett Co., Inc. : June 19, 2017
finance.yahoo.com - June 19 at 5:18 PM
streetinsider.com logoLannett (LCI) Granted FDA Approval for Niacin Extended-Release Tablets USP, 500 Mg & 1000 Mg
www.streetinsider.com - June 19 at 11:57 AM
seekingalpha.com logoFDA approves Lannett's Niacin USP, 500 mg and 1000 mg
seekingalpha.com - June 19 at 11:56 AM
prnewswire.com logoLannett Receives Approval For Niacin Extended-Release Tablets USP, 500 Mg And ...
www.prnewswire.com - June 19 at 11:56 AM
finance.yahoo.com logoLannett Receives Approval For Niacin Extended-Release Tablets USP, 500 Mg And 1000 Mg
finance.yahoo.com - June 19 at 11:56 AM
finance.yahoo.com logoFeatured Company News - Lannett Announces Approval for Amantadine Hydrochloride Capsules USP, 100 mg; Set to Launch Before the Flu Season
finance.yahoo.com - June 19 at 11:56 AM
streetinsider.com logoLannett (LCI) Receives FDA Approval For Amantadine Hydrochloride Capsules USP, 100 mg
www.streetinsider.com - June 17 at 11:50 PM
prnewswire.com logoLannett Announces Approval For Amantadine Hydrochloride Capsules USP, 100 mg - PR Newswire (press release)
www.prnewswire.com - June 16 at 7:12 PM
finance.yahoo.com logoLannett Announces Approval For Amantadine Hydrochloride Capsules USP, 100 mg
finance.yahoo.com - June 16 at 7:12 PM
finance.yahoo.com logoLannett Co., Inc. :LCI-US: Earnings Analysis: Q3, 2017 By the Numbers : June 16, 2017
finance.yahoo.com - June 16 at 7:12 PM
streetinsider.com logoLannett (LCI) Receives FDA Approval For Amantadine Hydrochloride Capsules USP, 100 mg - StreetInsider.com
www.streetinsider.com - June 16 at 7:16 AM
americanbankingnews.com logoComparing Lannett Co (LCI) & Neos Therapeutics (NEOS)
www.americanbankingnews.com - June 13 at 8:17 AM
americanbankingnews.com logoHead-To-Head Analysis: AMAG Pharmaceuticals (AMAG) & Lannett Co (LCI)
www.americanbankingnews.com - June 12 at 10:52 AM
americanbankingnews.com logoLannett Company, Inc. (LCI) Rating Reiterated by Oppenheimer Holdings Inc.
www.americanbankingnews.com - June 11 at 9:02 AM
americanbankingnews.com logoLannett Company, Inc. (LCI) Expected to Announce Quarterly Sales of $162.91 Million
www.americanbankingnews.com - June 11 at 8:52 AM
americanbankingnews.com logoZacks: Analysts Expect Lannett Company, Inc. (LCI) Will Post Earnings of $0.74 Per Share
www.americanbankingnews.com - June 9 at 4:30 PM
americanbankingnews.com logoLannett Company, Inc. (LCI) Rating Lowered to Hold at ValuEngine
www.americanbankingnews.com - June 4 at 9:20 AM
americanbankingnews.com logoLannett Company, Inc. (LCI) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - June 2 at 10:50 AM
prnewswire.com logoLannett Company's Chief Executive Officer Receives High Rating - PR Newswire (press release)
www.prnewswire.com - May 26 at 7:04 PM
finance.yahoo.com logoLannett Company's Chief Executive Officer Receives High Rating
finance.yahoo.com - May 26 at 7:04 PM
streetinsider.com logoLannett (LCI) Reports FDA Approval for Levocetirizine Dihydrochloride Oral Solution, 2.5 mg/5 mL
www.streetinsider.com - May 17 at 6:14 PM
americanbankingnews.com logo Brokerages Expect Lannett Company, Inc. (LCI) Will Post Quarterly Sales of $162.91 Million
www.americanbankingnews.com - May 17 at 12:00 PM
prnewswire.com logoLannett Announces Approval For Levocetirizine Dihydrochloride Oral Solution, 2.5 mg/5 mL (0.5 mg/mL) - PR Newswire (press release)
www.prnewswire.com - May 16 at 6:06 PM
finance.yahoo.com logoLannett Announces Approval For Levocetirizine Dihydrochloride Oral Solution, 2.5 mg/5 mL (0.5 mg/mL)
finance.yahoo.com - May 16 at 10:46 AM
americanbankingnews.com logo Analysts Anticipate Lannett Company, Inc. (LCI) Will Announce Earnings of $0.74 Per Share
www.americanbankingnews.com - May 15 at 10:10 AM
prnewswire.com logoLannett Voluntarily Pays Down Remaining $25 Million Principal ... - PR Newswire (press release)
www.prnewswire.com - May 10 at 12:57 PM
finance.yahoo.com logoLannett Voluntarily Pays Down Remaining $25 Million Principal Balance Of Revolving Credit Facility
finance.yahoo.com - May 9 at 12:02 PM
americanbankingnews.com logoLannett Company, Inc. (LCI) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - May 8 at 12:42 PM
fool.com logoHere's Why Lannett Company, Inc. Is Having a Lousy Day - Motley Fool
www.fool.com - May 5 at 6:14 PM
finance.yahoo.com logoLannett Co., Inc. – Value Analysis (NYSE:LCI) : May 5, 2017
finance.yahoo.com - May 5 at 6:14 PM
americanbankingnews.com logoOppenheimer Holdings Equities Analysts Reduce Earnings Estimates for Lannett Company, Inc. (LCI)
www.americanbankingnews.com - May 5 at 4:16 PM
americanbankingnews.com logoZacks Investment Research Downgrades Lannett Company, Inc. (LCI) to Hold
www.americanbankingnews.com - May 5 at 12:46 AM
americanbankingnews.com logoFY2017 EPS Estimates for Lannett Company, Inc. Cut by Oppenheimer Holdings (LCI)
www.americanbankingnews.com - May 4 at 3:04 PM
finance.yahoo.com logoLannett Co., Inc. breached its 50 day moving average in a Bearish Manner : LCI-US : May 4, 2017
finance.yahoo.com - May 4 at 11:59 AM
americanbankingnews.com logoLannett Company, Inc. (LCI) Given a $27.00 Price Target by Roth Capital Analysts
www.americanbankingnews.com - May 4 at 1:09 AM
americanbankingnews.com logoLannett Company, Inc. (LCI) Issues Earnings Results
www.americanbankingnews.com - May 4 at 12:22 AM
americanbankingnews.com logoLannett Company, Inc. (LCI) Receives "Hold" Rating from Oppenheimer Holdings Inc.
www.americanbankingnews.com - May 3 at 5:56 PM
finance.yahoo.com logoHere's Why Lannett Company, Inc. Is Having a Lousy Day
finance.yahoo.com - May 3 at 5:22 PM
fool.com logoHere's Why Lannett Company, Inc. Is Having a Lousy Day
www.fool.com - May 3 at 1:19 PM
seekingalpha.com logoLannett (LCI) Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - May 3 at 8:14 AM
finance.yahoo.com logoEdited Transcript of LCI earnings conference call or presentation 2-May-17 8:30pm GMT
finance.yahoo.com - May 3 at 8:14 AM
finance.yahoo.com logoLannett Reports Fiscal 2017 Third-Quarter Financial Results
finance.yahoo.com - May 2 at 7:57 PM
finance.yahoo.com logoLannett misses Street 3Q forecasts
finance.yahoo.com - May 2 at 7:57 PM
americanbankingnews.com logoLannett Company (LCI) Given Daily Coverage Optimism Rating of -0.20
www.americanbankingnews.com - May 2 at 5:04 PM
americanbankingnews.com logoBMO Capital Markets Initiates Coverage on Lannett Company, Inc. (LCI)
www.americanbankingnews.com - May 1 at 10:26 AM
prnewswire.com logoLannett To Participate At Three Investor Conferences In May - PR Newswire (press release)
www.prnewswire.com - April 29 at 8:54 AM

Social

Chart

Lannett Co (LCI) Chart for Tuesday, June, 27, 2017

This page was last updated on 6/27/2017 by MarketBeat.com Staff